Pfizer Inc (PFE):企業の財務・戦略的SWOT分析

◆英語タイトル:Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1650
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:118
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pfizer Inc (PFE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc (Pfizer) discovers, develops, manufactures and commercializes biopharmaceuticals and generic and branded pharmaceuticals. The company offers products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. The company provides its products in the North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

Apr 28,2020 Pfizer Selects EV ARC Solar-Powered EV Charging Station For Sustainable Workplace Charging
Apr 28,2020 Pfizer reports first-quarter 2020 results
Apr 22,2020 Mylan Statement regarding European Commission’s Conditional Approval of the Combination of Mylan and Pfizer’s Upjohn Division
Apr 10,2020 Pfizer identifies lead coronavirus drug candidate

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Pfizer Inc – Key Facts
Pfizer Inc – Key Employees
Pfizer Inc – Key Employee Biographies
Pfizer Inc – Major Products and Services
Pfizer Inc – History
Pfizer Inc – Company Statement
Pfizer Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Pfizer Inc – Business Description
Business Segment: Biopharma
Overview
Performance
Key Stats
Business Segment: Consumer Healthcare
Performance
Business Segment: Upjohn
Overview
Performance
Key Stats
Geographical Segment: Developed Europe
Target Markets
Performance
Geographical Segment: Developed Rest of World
Target Markets
Performance
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Pfizer Inc – Corporate Strategy
Pfizer Inc – SWOT Analysis
SWOT Analysis – Overview
Pfizer Inc – Strengths
Pfizer Inc – Weaknesses
Pfizer Inc – Opportunities
Pfizer Inc – Threats
Pfizer Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Pfizer Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2020: Pfizer Selects EV ARC Solar-Powered EV Charging Station For Sustainable Workplace Charging
Apr 28, 2020: Pfizer reports first-quarter 2020 results
Apr 22, 2020: Mylan Statement regarding European Commission’s Conditional Approval of the Combination of Mylan and Pfizer’s Upjohn Division
Apr 10, 2020: Pfizer identifies lead coronavirus drug candidate
Apr 09, 2020: Pfizer advances battle against Covid-19 on multiple fronts
Apr 08, 2020: ISPE award honors new Pfizer facility that expands company’s growing portfolio
Apr 06, 2020: Pfizer and the Pfizer Foundation donate $40 million in charitable grants, expand product access and mobilize colleagues to combat covid-19 pandemic
Apr 03, 2020: ICON signs new service agreement with Pfizer
Apr 02, 2020: Susan Desmond-hellmann elected to Pfizer’s Board of Directors
Apr 01, 2020: Medical professionals across Merck & Co., Pfizer and Eli Lilly and Company activate to support health systems, first responders and patients amid COVID-19 pandemic
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Pfizer Inc, Key Facts
Pfizer Inc, Key Employees
Pfizer Inc, Key Employee Biographies
Pfizer Inc, Major Products and Services
Pfizer Inc, History
Pfizer Inc, Subsidiaries
Pfizer Inc, Affiliate
Pfizer Inc, Joint Venture
Pfizer Inc, Key Competitors
Pfizer Inc, Ratios based on current share price
Pfizer Inc, Annual Ratios
Pfizer Inc, Annual Ratios (Cont...1)
Pfizer Inc, Annual Ratios (Cont...2)
Pfizer Inc, Interim Ratios
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Pfizer Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Pfizer Inc, Performance Chart (2015 - 2019)
Pfizer Inc, Ratio Charts
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Pfizer Inc (PFE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Skyworth Digital Holdings Limited:企業の戦略・SWOT・財務分析
    Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Yandex NV (YNDX):企業の財務・戦略的SWOT分析
    Yandex NV (YNDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Maxim Power Corp. (MXG)-エネルギー分野:企業M&A・提携分析
    Summary Maxim Power Corp. (Maxim) is an independent power producing company that acquires, develops, owns and operates power generation facilities and sells electricity and heat. The corporation generates electricity using various fuel sources including coal, natural gas, and wind, nuclear, hydro an …
  • Sime Darby Berhad (SIME)-エネルギー分野:企業M&A・提携分析
    Summary Sime Darby Berhad (Sime Darby) is a trading and logistics company. It operates as a conglomerate that provides diversified products and services through its subsidiaries, affiliates, and joint ventures. The company cultivates oil palm, rubber, sugar cane, and cattle rearing and produces oil …
  • Key Petroleum Ltd (KEY):企業の財務・戦略的SWOT分析
    Summary Key Petroleum Ltd (Key Petroleum) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company carries out projects such as Canning Basin and Perth Basin. It holds interest in exploration permits such as EP 438, EP 448, EP 104/ …
  • iKang Healthcare Group Inc:戦略・SWOT・企業財務分析
    iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report Summary iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kwantas Corporation Berhad:企業の戦略・SWOT・財務分析
    Kwantas Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Kwantas Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Geron Corp (GERN):製薬・医療:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Texas Municipal Power Agency:企業の戦略的SWOT分析
    Texas Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • RATP Group:企業の戦略・SWOT・財務情報
    RATP Group - Strategy, SWOT and Corporate Finance Report Summary RATP Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Restaurant Brands New Zealand Limited
    Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • EWE AG:石油・ガス:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Aditya Birla Sun Life Insurance Company Limited:企業の戦略・SWOT・財務分析
    Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • TOTAL S.A.:戦略・SWOT・企業財務分析
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Blackbird Plc (BIRD):企業の財務・戦略的SWOT分析
    Summary Blackbird plc (Blackbird), formerly Forbidden Technologies plc, is a technology company that develops and commercializes cloud-based video technology. The company offers products such as FORscene- cloud-based post-production platform, captevate- online video editor and eva-video social netwo …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MTBC Inc (MTBC):企業の財務・戦略的SWOT分析
    Summary MTBC Inc (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, patient engagement, practice management, and mhealth. Its services include medical billing, medical transcription, consulta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆